Global Biosimilar Drug Supply, Demand and Key Producers, 2024-2030

Description

The global Biosimilar Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.

East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.

In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.

This report studies the global Biosimilar Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Biosimilar Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biosimilar Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Biosimilar Drug total production and demand, 2019-2030, (K Dose)
Global Biosimilar Drug total production value, 2019-2030, (USD Million)
Global Biosimilar Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Dose)
Global Biosimilar Drug consumption by region & country, CAGR, 2019-2030 & (K Dose)
U.S. VS China: Biosimilar Drug domestic production, consumption, key domestic manufacturers and share
Global Biosimilar Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Dose)
Global Biosimilar Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Dose)
Global Biosimilar Drug production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Dose).

This reports profiles key players in the global Biosimilar Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, Henlius, Amgen, Eli Lilly, Sandoz, Changchun High Tech and Innovent, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biosimilar Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Biosimilar Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Biosimilar Drug Market, Segmentation by Type
    Injection
    Tablets
    Other Types

Global Biosimilar Drug Market, Segmentation by Application
    Ankylosing Spondylitis
    Tumor
    Rheumatoid Arthrtis
    Cardiovascular
    Other Application

Companies Profiled:
    CP Guojian Pharma
    Biotech Pharma
    Celgen Pharma
    Henlius
    Amgen
    Eli Lilly
    Sandoz
    Changchun High Tech
    Innovent

Key Questions Answered
1. How big is the global Biosimilar Drug market?
2. What is the demand of the global Biosimilar Drug market?
3. What is the year over year growth of the global Biosimilar Drug market?
4. What is the production and production value of the global Biosimilar Drug market?
5. Who are the key producers in the global Biosimilar Drug market?

Table of Contents

1 Supply Summary
    1.1 Biosimilar Drug Introduction
    1.2 World Biosimilar Drug Supply & Forecast
        1.2.1 World Biosimilar Drug Production Value (2019 & 2023 & 2030)
        1.2.2 World Biosimilar Drug Production (2019-2030)
        1.2.3 World Biosimilar Drug Pricing Trends (2019-2030)
    1.3 World Biosimilar Drug Production by Region (Based on Production Site)
        1.3.1 World Biosimilar Drug Production Value by Region (2019-2030)
        1.3.2 World Biosimilar Drug Production by Region (2019-2030)
        1.3.3 World Biosimilar Drug Average Price by Region (2019-2030)
        1.3.4 North America Biosimilar Drug Production (2019-2030)
        1.3.5 Europe Biosimilar Drug Production (2019-2030)
        1.3.6 China Biosimilar Drug Production (2019-2030)
        1.3.7 Japan Biosimilar Drug Production (2019-2030)
        1.3.8 Singapore Biosimilar Drug Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Biosimilar Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Biosimilar Drug Major Market Trends

2 Demand Summary
    2.1 World Biosimilar Drug Demand (2019-2030)
    2.2 World Biosimilar Drug Consumption by Region
        2.2.1 World Biosimilar Drug Consumption by Region (2019-2024)
        2.2.2 World Biosimilar Drug Consumption Forecast by Region (2025-2030)
    2.3 United States Biosimilar Drug Consumption (2019-2030)
    2.4 China Biosimilar Drug Consumption (2019-2030)
    2.5 Europe Biosimilar Drug Consumption (2019-2030)
    2.6 Japan Biosimilar Drug Consumption (2019-2030)
    2.7 South Korea Biosimilar Drug Consumption (2019-2030)
    2.8 ASEAN Biosimilar Drug Consumption (2019-2030)
    2.9 India Biosimilar Drug Consumption (2019-2030)

3 World Biosimilar Drug Manufacturers Competitive Analysis
    3.1 World Biosimilar Drug Production Value by Manufacturer (2019-2024)
    3.2 World Biosimilar Drug Production by Manufacturer (2019-2024)
    3.3 World Biosimilar Drug Average Price by Manufacturer (2019-2024)
    3.4 Biosimilar Drug Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Biosimilar Drug Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Biosimilar Drug in 2023
        3.5.3 Global Concentration Ratios (CR8) for Biosimilar Drug in 2023
    3.6 Biosimilar Drug Market: Overall Company Footprint Analysis
        3.6.1 Biosimilar Drug Market: Region Footprint
        3.6.2 Biosimilar Drug Market: Company Product Type Footprint
        3.6.3 Biosimilar Drug Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Biosimilar Drug Production Value Comparison
        4.1.1 United States VS China: Biosimilar Drug Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Biosimilar Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Biosimilar Drug Production Comparison
        4.2.1 United States VS China: Biosimilar Drug Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Biosimilar Drug Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Biosimilar Drug Consumption Comparison
        4.3.1 United States VS China: Biosimilar Drug Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Biosimilar Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Biosimilar Drug Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Biosimilar Drug Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Biosimilar Drug Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Biosimilar Drug Production (2019-2024)
    4.5 China Based Biosimilar Drug Manufacturers and Market Share
        4.5.1 China Based Biosimilar Drug Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Biosimilar Drug Production Value (2019-2024)
        4.5.3 China Based Manufacturers Biosimilar Drug Production (2019-2024)
    4.6 Rest of World Based Biosimilar Drug Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Biosimilar Drug Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Biosimilar Drug Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Biosimilar Drug Production (2019-2024)

5 Market Analysis by Type
    5.1 World Biosimilar Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Injection
        5.2.2 Tablets
        5.2.3 Other Types
    5.3 Market Segment by Type
        5.3.1 World Biosimilar Drug Production by Type (2019-2030)
        5.3.2 World Biosimilar Drug Production Value by Type (2019-2030)
        5.3.3 World Biosimilar Drug Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Biosimilar Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Ankylosing Spondylitis
        6.2.2 Tumor
        6.2.3 Rheumatoid Arthrtis
        6.2.4 Cardiovascular
        6.2.5 Other Application
    6.3 Market Segment by Application
        6.3.1 World Biosimilar Drug Production by Application (2019-2030)
        6.3.2 World Biosimilar Drug Production Value by Application (2019-2030)
        6.3.3 World Biosimilar Drug Average Price by Application (2019-2030)

7 Company Profiles
    7.1 CP Guojian Pharma
        7.1.1 CP Guojian Pharma Details
        7.1.2 CP Guojian Pharma Major Business
        7.1.3 CP Guojian Pharma Biosimilar Drug Product and Services
        7.1.4 CP Guojian Pharma Biosimilar Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 CP Guojian Pharma Recent Developments/Updates
        7.1.6 CP Guojian Pharma Competitive Strengths & Weaknesses
    7.2 Biotech Pharma
        7.2.1 Biotech Pharma Details
        7.2.2 Biotech Pharma Major Business
        7.2.3 Biotech Pharma Biosimilar Drug Product and Services
        7.2.4 Biotech Pharma Biosimilar Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Biotech Pharma Recent Developments/Updates
        7.2.6 Biotech Pharma Competitive Strengths & Weaknesses
    7.3 Celgen Pharma
        7.3.1 Celgen Pharma Details
        7.3.2 Celgen Pharma Major Business
        7.3.3 Celgen Pharma Biosimilar Drug Product and Services
        7.3.4 Celgen Pharma Biosimilar Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Celgen Pharma Recent Developments/Updates
        7.3.6 Celgen Pharma Competitive Strengths & Weaknesses
    7.4 Henlius
        7.4.1 Henlius Details
        7.4.2 Henlius Major Business
        7.4.3 Henlius Biosimilar Drug Product and Services
        7.4.4 Henlius Biosimilar Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Henlius Recent Developments/Updates
        7.4.6 Henlius Competitive Strengths & Weaknesses
    7.5 Amgen
        7.5.1 Amgen Details
        7.5.2 Amgen Major Business
        7.5.3 Amgen Biosimilar Drug Product and Services
        7.5.4 Amgen Biosimilar Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Amgen Recent Developments/Updates
        7.5.6 Amgen Competitive Strengths & Weaknesses
    7.6 Eli Lilly
        7.6.1 Eli Lilly Details
        7.6.2 Eli Lilly Major Business
        7.6.3 Eli Lilly Biosimilar Drug Product and Services
        7.6.4 Eli Lilly Biosimilar Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Eli Lilly Recent Developments/Updates
        7.6.6 Eli Lilly Competitive Strengths & Weaknesses
    7.7 Sandoz
        7.7.1 Sandoz Details
        7.7.2 Sandoz Major Business
        7.7.3 Sandoz Biosimilar Drug Product and Services
        7.7.4 Sandoz Biosimilar Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Sandoz Recent Developments/Updates
        7.7.6 Sandoz Competitive Strengths & Weaknesses
    7.8 Changchun High Tech
        7.8.1 Changchun High Tech Details
        7.8.2 Changchun High Tech Major Business
        7.8.3 Changchun High Tech Biosimilar Drug Product and Services
        7.8.4 Changchun High Tech Biosimilar Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Changchun High Tech Recent Developments/Updates
        7.8.6 Changchun High Tech Competitive Strengths & Weaknesses
    7.9 Innovent
        7.9.1 Innovent Details
        7.9.2 Innovent Major Business
        7.9.3 Innovent Biosimilar Drug Product and Services
        7.9.4 Innovent Biosimilar Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Innovent Recent Developments/Updates
        7.9.6 Innovent Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Biosimilar Drug Industry Chain
    8.2 Biosimilar Drug Upstream Analysis
        8.2.1 Biosimilar Drug Core Raw Materials
        8.2.2 Main Manufacturers of Biosimilar Drug Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Biosimilar Drug Production Mode
    8.6 Biosimilar Drug Procurement Model
    8.7 Biosimilar Drug Industry Sales Model and Sales Channels
        8.7.1 Biosimilar Drug Sales Model
        8.7.2 Biosimilar Drug Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Biosimilar Drug Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Biosimilar Drug Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Biosimilar Drug Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Biosimilar Drug Production Value Market Share by Region (2019-2024)
    Table 5. World Biosimilar Drug Production Value Market Share by Region (2025-2030)
    Table 6. World Biosimilar Drug Production by Region (2019-2024) & (K Dose)
    Table 7. World Biosimilar Drug Production by Region (2025-2030) & (K Dose)
    Table 8. World Biosimilar Drug Production Market Share by Region (2019-2024)
    Table 9. World Biosimilar Drug Production Market Share by Region (2025-2030)
    Table 10. World Biosimilar Drug Average Price by Region (2019-2024) & (USD/Dose)
    Table 11. World Biosimilar Drug Average Price by Region (2025-2030) & (USD/Dose)
    Table 12. Biosimilar Drug Major Market Trends
    Table 13. World Biosimilar Drug Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Dose)
    Table 14. World Biosimilar Drug Consumption by Region (2019-2024) & (K Dose)
    Table 15. World Biosimilar Drug Consumption Forecast by Region (2025-2030) & (K Dose)
    Table 16. World Biosimilar Drug Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Biosimilar Drug Producers in 2023
    Table 18. World Biosimilar Drug Production by Manufacturer (2019-2024) & (K Dose)
    Table 19. Production Market Share of Key Biosimilar Drug Producers in 2023
    Table 20. World Biosimilar Drug Average Price by Manufacturer (2019-2024) & (USD/Dose)
    Table 21. Global Biosimilar Drug Company Evaluation Quadrant
    Table 22. World Biosimilar Drug Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Biosimilar Drug Production Site of Key Manufacturer
    Table 24. Biosimilar Drug Market: Company Product Type Footprint
    Table 25. Biosimilar Drug Market: Company Product Application Footprint
    Table 26. Biosimilar Drug Competitive Factors
    Table 27. Biosimilar Drug New Entrant and Capacity Expansion Plans
    Table 28. Biosimilar Drug Mergers & Acquisitions Activity
    Table 29. United States VS China Biosimilar Drug Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Biosimilar Drug Production Comparison, (2019 & 2023 & 2030) & (K Dose)
    Table 31. United States VS China Biosimilar Drug Consumption Comparison, (2019 & 2023 & 2030) & (K Dose)
    Table 32. United States Based Biosimilar Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Biosimilar Drug Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Biosimilar Drug Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Biosimilar Drug Production (2019-2024) & (K Dose)
    Table 36. United States Based Manufacturers Biosimilar Drug Production Market Share (2019-2024)
    Table 37. China Based Biosimilar Drug Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Biosimilar Drug Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Biosimilar Drug Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Biosimilar Drug Production (2019-2024) & (K Dose)
    Table 41. China Based Manufacturers Biosimilar Drug Production Market Share (2019-2024)
    Table 42. Rest of World Based Biosimilar Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Biosimilar Drug Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Biosimilar Drug Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Biosimilar Drug Production (2019-2024) & (K Dose)
    Table 46. Rest of World Based Manufacturers Biosimilar Drug Production Market Share (2019-2024)
    Table 47. World Biosimilar Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Biosimilar Drug Production by Type (2019-2024) & (K Dose)
    Table 49. World Biosimilar Drug Production by Type (2025-2030) & (K Dose)
    Table 50. World Biosimilar Drug Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Biosimilar Drug Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Biosimilar Drug Average Price by Type (2019-2024) & (USD/Dose)
    Table 53. World Biosimilar Drug Average Price by Type (2025-2030) & (USD/Dose)
    Table 54. World Biosimilar Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Biosimilar Drug Production by Application (2019-2024) & (K Dose)
    Table 56. World Biosimilar Drug Production by Application (2025-2030) & (K Dose)
    Table 57. World Biosimilar Drug Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Biosimilar Drug Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Biosimilar Drug Average Price by Application (2019-2024) & (USD/Dose)
    Table 60. World Biosimilar Drug Average Price by Application (2025-2030) & (USD/Dose)
    Table 61. CP Guojian Pharma Basic Information, Manufacturing Base and Competitors
    Table 62. CP Guojian Pharma Major Business
    Table 63. CP Guojian Pharma Biosimilar Drug Product and Services
    Table 64. CP Guojian Pharma Biosimilar Drug Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. CP Guojian Pharma Recent Developments/Updates
    Table 66. CP Guojian Pharma Competitive Strengths & Weaknesses
    Table 67. Biotech Pharma Basic Information, Manufacturing Base and Competitors
    Table 68. Biotech Pharma Major Business
    Table 69. Biotech Pharma Biosimilar Drug Product and Services
    Table 70. Biotech Pharma Biosimilar Drug Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Biotech Pharma Recent Developments/Updates
    Table 72. Biotech Pharma Competitive Strengths & Weaknesses
    Table 73. Celgen Pharma Basic Information, Manufacturing Base and Competitors
    Table 74. Celgen Pharma Major Business
    Table 75. Celgen Pharma Biosimilar Drug Product and Services
    Table 76. Celgen Pharma Biosimilar Drug Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Celgen Pharma Recent Developments/Updates
    Table 78. Celgen Pharma Competitive Strengths & Weaknesses
    Table 79. Henlius Basic Information, Manufacturing Base and Competitors
    Table 80. Henlius Major Business
    Table 81. Henlius Biosimilar Drug Product and Services
    Table 82. Henlius Biosimilar Drug Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Henlius Recent Developments/Updates
    Table 84. Henlius Competitive Strengths & Weaknesses
    Table 85. Amgen Basic Information, Manufacturing Base and Competitors
    Table 86. Amgen Major Business
    Table 87. Amgen Biosimilar Drug Product and Services
    Table 88. Amgen Biosimilar Drug Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Amgen Recent Developments/Updates
    Table 90. Amgen Competitive Strengths & Weaknesses
    Table 91. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 92. Eli Lilly Major Business
    Table 93. Eli Lilly Biosimilar Drug Product and Services
    Table 94. Eli Lilly Biosimilar Drug Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Eli Lilly Recent Developments/Updates
    Table 96. Eli Lilly Competitive Strengths & Weaknesses
    Table 97. Sandoz Basic Information, Manufacturing Base and Competitors
    Table 98. Sandoz Major Business
    Table 99. Sandoz Biosimilar Drug Product and Services
    Table 100. Sandoz Biosimilar Drug Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Sandoz Recent Developments/Updates
    Table 102. Sandoz Competitive Strengths & Weaknesses
    Table 103. Changchun High Tech Basic Information, Manufacturing Base and Competitors
    Table 104. Changchun High Tech Major Business
    Table 105. Changchun High Tech Biosimilar Drug Product and Services
    Table 106. Changchun High Tech Biosimilar Drug Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Changchun High Tech Recent Developments/Updates
    Table 108. Innovent Basic Information, Manufacturing Base and Competitors
    Table 109. Innovent Major Business
    Table 110. Innovent Biosimilar Drug Product and Services
    Table 111. Innovent Biosimilar Drug Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 112. Global Key Players of Biosimilar Drug Upstream (Raw Materials)
    Table 113. Biosimilar Drug Typical Customers
    Table 114. Biosimilar Drug Typical Distributors
List of Figure
    Figure 1. Biosimilar Drug Picture
    Figure 2. World Biosimilar Drug Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Biosimilar Drug Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Biosimilar Drug Production (2019-2030) & (K Dose)
    Figure 5. World Biosimilar Drug Average Price (2019-2030) & (USD/Dose)
    Figure 6. World Biosimilar Drug Production Value Market Share by Region (2019-2030)
    Figure 7. World Biosimilar Drug Production Market Share by Region (2019-2030)
    Figure 8. North America Biosimilar Drug Production (2019-2030) & (K Dose)
    Figure 9. Europe Biosimilar Drug Production (2019-2030) & (K Dose)
    Figure 10. China Biosimilar Drug Production (2019-2030) & (K Dose)
    Figure 11. Japan Biosimilar Drug Production (2019-2030) & (K Dose)
    Figure 12. Singapore Biosimilar Drug Production (2019-2030) & (K Dose)
    Figure 13. Biosimilar Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Biosimilar Drug Consumption (2019-2030) & (K Dose)
    Figure 16. World Biosimilar Drug Consumption Market Share by Region (2019-2030)
    Figure 17. United States Biosimilar Drug Consumption (2019-2030) & (K Dose)
    Figure 18. China Biosimilar Drug Consumption (2019-2030) & (K Dose)
    Figure 19. Europe Biosimilar Drug Consumption (2019-2030) & (K Dose)
    Figure 20. Japan Biosimilar Drug Consumption (2019-2030) & (K Dose)
    Figure 21. South Korea Biosimilar Drug Consumption (2019-2030) & (K Dose)
    Figure 22. ASEAN Biosimilar Drug Consumption (2019-2030) & (K Dose)
    Figure 23. India Biosimilar Drug Consumption (2019-2030) & (K Dose)
    Figure 24. Producer Shipments of Biosimilar Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Biosimilar Drug Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Biosimilar Drug Markets in 2023
    Figure 27. United States VS China: Biosimilar Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Biosimilar Drug Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States VS China: Biosimilar Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 30. United States Based Manufacturers Biosimilar Drug Production Market Share 2023
    Figure 31. China Based Manufacturers Biosimilar Drug Production Market Share 2023
    Figure 32. Rest of World Based Manufacturers Biosimilar Drug Production Market Share 2023
    Figure 33. World Biosimilar Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 34. World Biosimilar Drug Production Value Market Share by Type in 2023
    Figure 35. Injection
    Figure 36. Tablets
    Figure 37. Other Types
    Figure 38. World Biosimilar Drug Production Market Share by Type (2019-2030)
    Figure 39. World Biosimilar Drug Production Value Market Share by Type (2019-2030)
    Figure 40. World Biosimilar Drug Average Price by Type (2019-2030) & (USD/Dose)
    Figure 41. World Biosimilar Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 42. World Biosimilar Drug Production Value Market Share by Application in 2023
    Figure 43. Ankylosing Spondylitis
    Figure 44. Tumor
    Figure 45. Rheumatoid Arthrtis
    Figure 46. Cardiovascular
    Figure 47. Other Application
    Figure 48. World Biosimilar Drug Production Market Share by Application (2019-2030)
    Figure 49. World Biosimilar Drug Production Value Market Share by Application (2019-2030)
    Figure 50. World Biosimilar Drug Average Price by Application (2019-2030) & (USD/Dose)
    Figure 51. Biosimilar Drug Industry Chain
    Figure 52. Biosimilar Drug Procurement Model
    Figure 53. Biosimilar Drug Sales Model
    Figure 54. Biosimilar Drug Sales Channels, Direct Sales, and Distribution
    Figure 55. Methodology
    Figure 56. Research Process and Data Source

Companies Mentioned

CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent